EDIT vs TRV · rev $32.3M vs P/E 14, rev $48.83B
Editas Medicine Inc (EDIT) versus The Travelers Companies Inc (TRV) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
The Travelers Companies Inc (TRV) is a insurance - property & casualty company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported TRV revenue for 2025-12-31 was $48.83B. Net income was $6.29B. Revenue was up 5.2% from 2024-12-31 to 2025-12-31. TRV currently screens at market cap $59.84B and trailing P/E 14.4.
EDIT currently screens at market cap $375.2M. TRV currently screens at market cap $59.84B and trailing P/E 14.4.
Not investment advice. Open the EDIT and TRV stock pages for the full models.
Not investment advice.